Two Sigma Advisers’s Biomea Fusion BMEA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-105,800
Closed -$131K 301
2025
Q4
$131K Sell
105,800
-160,900
-60% -$225K ﹤0.01% 2185
2025
Q3
$539K Sell
266,700
-30,100
-10% -$55.1K ﹤0.01% 1732
2025
Q2
$534K Sell
296,800
-194,200
-40% -$374K ﹤0.01% 1718
2025
Q1
$1.05M Buy
491,000
+31,500
+7% +$107K ﹤0.01% 1452
2024
Q4
$1.78M Buy
459,500
+341,900
+291% +$2.72M ﹤0.01% 1172
2024
Q3
$1.19M Buy
117,600
+6,900
+6% +$44.8K ﹤0.01% 1333
2024
Q2
$498K Buy
+110,700
New +$1.13M ﹤0.01% 1882
2024
Q1
Sell
-59,700
Closed -$867K 2463
2023
Q4
$867K Sell
59,700
-247,100
-81% -$3M ﹤0.01% 1702
2023
Q3
$4.22M Buy
+306,800
New +$5.53M 0.01% 816

Other funds holding BMEA

Two Sigma Advisers's BMEA Position: Q1 2026 in Review

Two Sigma Advisers sold out of Biomea Fusion (BMEA) in Q1 2026, closing a stake of 105,800 shares — an estimated $131K sold.

Two Sigma Advisers first reported a position in BMEA in Q3 2023 and held it in 9 quarters. The position peaked at $4.22M in Q3 2023. 65 funds tracked by Wall St. Rank hold BMEA as of Q1 2026.

  • Two Sigma Advisers reported no remaining Biomea Fusion position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 105,800 Biomea Fusion shares in Q1 2026, an estimated $131K.
  • Two Sigma Advisers first reported a position in Biomea Fusion in Q3 2023 and held it in 9 quarters.
  • Two Sigma Advisers's Biomea Fusion position peaked at $4.22M in Q3 2023.
  • 65 funds tracked by Wall St. Rank held Biomea Fusion as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.